These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34202685)

  • 1. Marine Antitumor Peptide Dolastatin 10: Biological Activity, Structural Modification and Synthetic Chemistry.
    Gao G; Wang Y; Hua H; Li D; Tang C
    Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34202685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and Development of Dolastatin 10-Derived Antibody Drug Conjugate Anticancer Drugs.
    Singh SB
    J Nat Prod; 2022 Mar; 85(3):666-687. PubMed ID: 35072477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticancer properties of novel dolastatin 10 analogs featuring five-membered heterocyclic rings with a linkable group at the C-terminus.
    Panja A; Sharma V; Mitra P; Bazylevich A; Drori C; Kayet A; Tobi D; Patsenker L; Firer M; Gellerman G
    Bioorg Med Chem; 2024 Jul; 109():117794. PubMed ID: 38875875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10.
    Pettit GR; Hogan F; Toms S
    J Nat Prod; 2011 May; 74(5):962-8. PubMed ID: 21534541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis and biological activity of dolastatin 16.
    Casalme LO; Yamauchi A; Sato A; Petitbois JG; Nogata Y; Yoshimura E; Okino T; Umezawa T; Matsuda F
    Org Biomol Chem; 2017 Feb; 15(5):1140-1150. PubMed ID: 28074955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15.
    Beckwith M; Urba WJ; Longo DL
    J Natl Cancer Inst; 1993 Mar; 85(6):483-8. PubMed ID: 8445676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic Agents. 603. Quinstatins: Exceptional Cancer Cell Growth Inhibitors.
    Pettit GR; Melody N; Chapuis JC
    J Nat Prod; 2017 Mar; 80(3):692-698. PubMed ID: 28211277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc.
    Turner T; Jackson WH; Pettit GR; Wells A; Kraft AS
    Prostate; 1998 Feb; 34(3):175-81. PubMed ID: 9492845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic agents 365. Dolastatin 10 SAR probes.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
    Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
    Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
    Kobayashi M; Natsume T; Tamaoki S; Watanabe J; Asano H; Mikami T; Miyasaka K; Miyazaki K; Gondo M; Sakakibara K; Tsukagoshi S
    Jpn J Cancer Res; 1997 Mar; 88(3):316-27. PubMed ID: 9140117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
    Bai R; Friedman SJ; Pettit GR; Hamel E
    Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Durkin KP; Boyd MR; Bai R; Hamel E; Schmidt JM; Chapuis JC
    Anticancer Drug Des; 1995 Oct; 10(7):529-44. PubMed ID: 7495477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification.
    Kalemkerian GP; Ou X; Adil MR; Rosati R; Khoulani MM; Madan SK; Pettit GR
    Cancer Chemother Pharmacol; 1999; 43(6):507-15. PubMed ID: 10321512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic agents. 599. Total synthesis of dolastatin 16.
    Pettit GR; Smith TH; Arce PM; Flahive EJ; Anderson CR; Chapuis JC; Xu JP; Groy TL; Belcher PE; Macdonald CB
    J Nat Prod; 2015 Mar; 78(3):476-85. PubMed ID: 25689568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Dolastatin 15 mimetic peptoids.
    Schmitt J; Bernd M; Kutscher B; Kessler H
    Bioorg Med Chem Lett; 1998 Feb; 8(4):385-8. PubMed ID: 9871690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytostatic properties of structure-simplified analogs of dolastatin 15.
    Hu MK; Huang WS
    J Pept Res; 1999 Dec; 54(6):460-7. PubMed ID: 10604591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kahalalide derivatives from the Indian sacoglossan mollusk Elysia grandifolia.
    Ashour M; Edrada R; Ebel R; Wray V; Wätjen W; Padmakumar K; Müller WE; Lin WH; Proksch P
    J Nat Prod; 2006 Nov; 69(11):1547-53. PubMed ID: 17125219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies with chiral isomers and with segments of the antimitotic marine peptide dolastatin 10.
    Bai RL; Pettit GR; Hamel E
    Biochem Pharmacol; 1990 Oct; 40(8):1859-64. PubMed ID: 2242019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
    Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
    Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.